A Helpful Suite of Clinical Resources for Your Practice
Access clinical tools for use with patients as well as multimedia resources providing information on diagnosis of irritable bowel syndrome with diarrhea (IBS-D) and treatment of IBS-D in adults with XIFAXAN.
IBS-D Symptom Questionnaire
A guide for patients to assess their symptoms of abdominal pain and diarrhea. Share with your patients prior to or during their visit to help facilitate a more productive discussion about their symptoms.Download PDF >
IBS-D Patient Discussion Guide
Encourages patients to have a discussion with their healthcare provider about their bowel habits using the Bristol Stool Form Scale. Have your patients complete the simple discussion questions to aid in discussions and symptom-based diagnosis of IBS-D.Download PDF >
Expert Discussion: ACG Recommendation for XIFAXAN
Watch Dr. Cash discuss the inclusion of XIFAXAN for the treatment of global IBS-D symptoms in the American College of Gastroenterology’s 2020 Clinical Guideline on Managing IBS.
Expert Discussion: Treating IBS-D as a Multi-Symptom Condition
Watch Dr. Brenner explain the importance of recognizing and treating multiple GI symptoms of IBS-D.
Expert Discussion: The Role of Dysbiosis in the Pathophysiology of IBS-D
Dr. Chang’s extensive research has focused on understanding how the GI microbiome can affect health and lead to disease. In this video, watch Dr. Chang explain the role of dysbiosis in the pathophysiology of IBS-D.
NP Perspective: Treating Adult Patients With IBS-D
Watch Christina J. Hanson, FNP, discuss her clinical experience in treating patients with IBS-D and what it’s like for patients to live with IBS-D symptoms.
Expert Discussion: Role Gut Microbiota May Play in the Etiology of IBS-D
Discussion from experts Mark Pimentel, MD, and Darren Brenner, MD, on the importance of gut microbiota for regulating physiologic processes and maintaining health and how perturbations have been associated with several diseases, including IBS-D. Watch to learn how bacterial imbalances may occur and how they may be associated with the pathophysiology of IBS-D in some patients.1-9
Expert Discussion: Managing IBS-D Symptoms
Discussion from experts Mark Pimentel, MD, and Darren Brenner, MD, on nonpharmacologic and pharmacologic interventions to help manage IBS-D symptoms. Includes a discussion from Joscelyn Greaves, NP, and one of her patients on the challenges of living with IBS-D.
Expert Discussion: Pathophysiology of IBS-D and Mechanism of Action of XIFAXAN
Discussion from expert Mark Pimentel, MD, on the complex pathophysiology of IBS-D and the mechanism of action of XIFAXAN.
XIFAXAN Dosing for IBS-D
Review the recommended dosing for IBS-D in adults and for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults. Refer to this dual-indication card for general XIFAXAN dosing – includes the ICD-10 code* for IBS-D.Download PDF >
XIFAXAN Patient Brochure
Informational brochure for patients that provides an overview of IBS-D and treatment with XIFAXAN, including how XIFAXAN works, how to take XIFAXAN, efficacy, safety, and most common side effects. Provide this brochure to patients to help them understand treatment with XIFAXAN.Download PDF >
XIFAXAN Prior Authorization Road Map
Step-by-step guide for completing prior authorization (PA) requirements for patients prescribed XIFAXAN, including common reasons for PA denials and guidance for Letters of Medical Necessity when needed. Download for guidance on PA requests, as well as information on electronic submissions with CoverMyMeds.Download PDF >
XIFAXAN Savings Card
Most eligible† patients with commercial insurance and coverage for XIFAXAN may pay as little as $0 for their XIFAXAN prescription. Maximum benefits and other restrictions apply.Get savings card >
XIFAXAN Product Details
Core information on XIFAXAN for the treatment of IBS-D in adults and for the reduction in risk of overt hepatic encephalopathy recurrence in adults. Provides an overview of symptom-based diagnosis of IBS-D, pathophysiology, and core efficacy and safety data for XIFAXAN, as well as information on insurance coverage. Obtain core product details about XIFAXAN in one informational brochure.Download PDF >
Expert Discussion: Treating IBS-D With XIFAXAN
Discussion from experts Mark Pimentel, MD, and Darren Brenner, MD, on the efficacy and safety of XIFAXAN in clinical trials. Includes a discussion from Joscelyn Greaves, NP, and one of her patients on how XIFAXAN was able to help manage her IBS-D. Learn how XIFAXAN may be able to help your adult patients with IBS-D and how to appropriately set expectations prior to treatment.
Expert Review: Efficacy and Safety of XIFAXAN
Presentation by expert Mark Pimentel, MD, on the efficacy and safety of XIFAXAN in clinical trials. Review key data supporting the use of XIFAXAN for your adult patients with IBS-D.
*The ICD-10 Codes and all other patient-access-related information are provided for informational purposes only. It is the treating physician’s responsibility to determine the proper diagnosis, treatment and applicable ICD-10 Code. Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product.
†Patient is not eligible if he/she participates in or seeks reimbursement or submits a claim for reimbursement to any federal or state healthcare program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by law. Patient must be enrolled in, and must seek reimbursement from or submit a claim for reimbursement to, a commercial insurance plan. Offer excludes full cash-paying patients. Maximum benefits and other restrictions apply. Visit https://xifaxan.copaysavingsprogram.com/ or call 1-866-XIFAXAN for full eligibility criteria, terms and conditions.